Balchem (BCPC) to Release Earnings on Thursday

Balchem (NASDAQ:BCPC - Get Free Report) is anticipated to announce its Q1 2025 earnings results before the market opens on Thursday, April 24th. Analysts expect Balchem to post earnings of $1.12 per share and revenue of $245.70 million for the quarter.

Balchem (NASDAQ:BCPC - Get Free Report) last posted its earnings results on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing analysts' consensus estimates of $1.11 by ($0.08). Balchem had a net margin of 13.47% and a return on equity of 11.37%. The company had revenue of $240.00 million during the quarter, compared to analysts' expectations of $239.96 million. On average, analysts expect Balchem to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Balchem Price Performance

Shares of NASDAQ BCPC traded up $0.58 during midday trading on Tuesday, hitting $157.50. The company had a trading volume of 338,963 shares, compared to its average volume of 130,851. Balchem has a twelve month low of $137.69 and a twelve month high of $186.03. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19. The firm has a market capitalization of $5.12 billion, a price-to-earnings ratio of 40.08, a price-to-earnings-growth ratio of 4.41 and a beta of 0.75. The business has a 50-day simple moving average of $164.68 and a two-hundred day simple moving average of $167.47.

Analysts Set New Price Targets

Several brokerages have issued reports on BCPC. Sidoti raised shares of Balchem to a "hold" rating in a research note on Tuesday, February 25th. StockNews.com cut Balchem from a "buy" rating to a "hold" rating in a research report on Tuesday, February 25th. Finally, HC Wainwright reaffirmed a "buy" rating and set a $190.00 price objective on shares of Balchem in a report on Monday, February 24th.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.